Monodur
In brief
- Monodur (isosorbide mononitrate) is generally prescription-only in major markets (including Australia); however, some pharmacies or online sellers may dispense it without a prescription—check your local pharmacy policy and regulations before purchase.
- Monodur is used mainly to prevent angina pectoris; it is a nitrate vasodilator that is metabolised to nitric oxide, causing venodilation and coronary vasodilation which reduces cardiac preload and myocardial oxygen demand.
- Usual doses: initial 20 mg once or twice daily; IR formulations often titrated to 20–40 mg twice daily; ER formulations typically 40–60 mg once daily—maintain a daily nitrate-free interval (about 10–12 hours) to reduce tolerance.
- Administered orally as immediate‑release tablets (commonly 10 mg, 20 mg) or extended‑release/retard tablets (commonly 40–60 mg).
- Onset of effect: immediate‑release tablets usually begin to work in about 30–60 minutes; extended‑release tablets have a slower onset with peak effect typically 1–4 hours after dosing.
- Duration of action: immediate‑release effects last roughly 4–6 hours; extended‑release preparations provide prolonged effect for up to ~12–24 hours depending on formulation—ensure a nitrate‑free period each day to avoid tolerance.
- Alcohol warning: avoid or minimise alcohol while taking monodur—alcohol can increase the risk of severe dizziness, fainting and low blood pressure when combined with nitrates.
- The most common side effect is headache (so‑called “nitrate headache”); dizziness, flushing and low blood pressure are also commonly reported.
- Would you like to try monodur without a prescription?
Critical Warnings & Restrictions (Patient Safety First)
Basic Monodur Information
- INN (International Nonproprietary Name): isosorbide mononitrate. Monoket is listed as a brand name in the raw data.
- Brand Names Available In Australia: not specified.
- ATC Code: C01DA14.
- Forms & Dosages: immediate‑release oral tablets 10 mg and 20 mg; extended‑release tablets 40 mg, 50 mg, 60 mg (pack sizes and formats vary).
- Manufacturers In Australia: Bayer AG; Atno Pharmaceuticals LLC; Krewel‑Meuselbach GmbH; Zentiva. (These are listed as global suppliers in the raw data.)
- Registration Status In Australia: not specified.
- OTC / Rx Classification: Prescription Only (Rx) in major markets according to the raw data.
High‑Risk Groups (Elderly, Pregnancy, Chronic Illness)
Patients frequently ask who must not take isosorbide mononitrate because safety matters most.
- Absolute Contraindications:
- Hypersensitivity to nitrates or isosorbide mononitrate.
- Acute circulatory failure or shock.
- Severe hypotension.
- Concomitant use with PDE‑5 inhibitors (sildenafil, tadalafil, vardenafil).
- Acute myocardial infarction with low filling pressures.
- Constrictive pericarditis or cardiac tamponade.
- Known severe anaemia.
- Use In Pregnancy And Lactation:
- Limited safety data exist; avoid unless a specialist advises otherwise.
Before starting isosorbide mononitrate you need to be screened for key risks and current medicines.
- Pre‑treatment Checklist:
- Measure baseline blood pressure lying and standing.
- Provide a full current medicine list, including erectile dysfunction treatments.
- Ask about recent head trauma or intracranial bleeding.
- Check for known severe anaemia or signs of shock.
- Note pregnancy, breastfeeding or plans to conceive.
Interaction With Activities (Driving, Workplace Safety Under Australian Law)
Common adverse effects include headache, dizziness, lightheadedness and rarely syncope.
These effects may impair the ability to drive or operate machinery safely.
Australian road and workplace safety laws expect drivers and operators to be fit for duty and free from medication‑related impairment.
Q&A — “Can I Drive After Taking It In Australia?”
Q: Can I drive after taking isosorbide mononitrate (Monodur)?
A: There is no guarantee you will be safe to drive after a dose.
If you feel dizzy, lightheaded or faint, do not drive or operate machinery.
Report side‑effects to your prescriber and follow your pharmacist’s advice.
Usage Basics
INN, Brand Names Available In Australia
The active ingredient is isosorbide mononitrate (INN).
Monoket is recorded in the raw data as a brand that supplies isosorbide mononitrate in multiple markets.
| Brand | Formulation | Strengths | Packaging |
|---|---|---|---|
| Monoket | Immediate‑release tablet | 10 mg, 20 mg | Blisters or bottles (20, 30, 60, 100) |
| Monoket (retard) | Extended‑release tablet | 40 mg, 50 mg, 60 mg | Blisters or bottles (28, 30, 60) |
| Generic / Other | IR and ER formulations | 10–60 mg range | Various blister sizes |
Legal Classification (TGA‑Approved, PBS‑Listed)
Isosorbide mononitrate is Prescription Only (Rx) in the markets recorded in the raw data.
In Australia check the TGA ARTG for current registered products and the PBS for any subsidy or listing changes.
- TGA
- Confirm product registration on the ARTG before advising on supply.
- PBS
- PBS listings and restrictions change; confirm current PBS schedule for subsidy status.
Dosing Guide
Standard Regimens (PBS Reference Dosing)
Typical initiating and maintenance doses recorded in the raw data are straightforward.
- Immediate‑release (IR): often 20 mg once or twice daily, with maintenance up to 20–40 mg twice daily.
- Extended‑release (ER): typically 40–60 mg once daily for once‑daily coverage.
- Tolerance avoidance: space doses and include a nitrate‑free interval; the raw data recommends a 7‑hour spacing for IR and a nitrate‑free period of at least 10–12 hours per day.
- Example Schedules:
- IR: 20 mg at 8:00 am and 20 mg at 2:00 pm (≈7‑hour gap) with a nitrate‑free evening.
- ER: 40–60 mg once daily in the morning with a nitrate‑free period overnight.
Adjustments For Comorbidities
- Children: not recommended — safety and efficacy not established.
- Elderly: no formal numeric adjustment but start at the lowest effective dose and monitor blood pressure closely.
- Renal impairment: use with caution and monitor for symptomatic hypotension.
- Hepatic impairment: caution advised; severe liver dysfunction may require lower starting doses.
Q&A — “What If I Miss A Dose?”
Q: I missed a dose. What should I do?
A: Take the missed dose as soon as you remember unless it’s within about four hours of the next scheduled dose.
Do not double doses to catch up.
If uncertain, contact your pharmacist or prescriber for tailored advice.
Interaction Chart
Food And Drinks (Alcohol, Coffee, Australian Diet Context)
Alcohol adds to the vasodilatory and hypotensive effects of nitrates and increases the risk of dizziness or fainting after a dose.
Caffeine does not have a direct pharmacological contraindication but can confuse reports of palpitations or headaches.
- Avoid alcohol within 4–6 hours of dosing where possible.
- Stay well hydrated on dosing days to reduce orthostatic symptoms.
- Keep a simple food plan if you experience post‑dose nausea or lightheadedness.
Common Drug Conflicts
Some interactions are severe and absolute; others require monitoring or dose adjustment.
| Interacting Drug Class | Risk Level | Practical Action |
|---|---|---|
| PDE‑5 Inhibitors (sildenafil, tadalafil, vardenafil) | High — Absolute Contraindication | Do not co‑prescribe or take concurrently. Patients must avoid ED medications. |
| Other Nitrates / Nicorandil | High — Additive Hypotension, Tolerance Issues | Avoid combined use unless specialist supervised. |
| Antihypertensives (ACE inhibitors, ARBs, CCBs, beta‑blockers) | Moderate | Monitor blood pressure and symptoms; consider dose adjustments. |
| Certain Antidepressants / Antipsychotics | Moderate | Monitor for potentiation of hypotension; counsel on fall risk. |
User Reports & Trends (Australian Patient Feedback)
Patients often describe a consistent pattern of benefits and side‑effects when using isosorbide mononitrate for angina prevention.
- Very common complaint: severe or persistent headache shortly after dosing, often called a “nitrate headache.”
- Dizziness and lightheadedness are frequent, especially during initiation or up‑titration.
- Many patients report good angina prevention when dosing and nitrate‑free intervals are correct.
- Concerns about ongoing prescription costs and rural access appear regularly in feedback.
- Tolerance developing when a nitrate‑free interval is not maintained is a common theme.
| Sentiment | Typical Themes | Prevalence (Anecdotal) |
|---|---|---|
| Positive | Reduced angina attacks, improved activity tolerance | Moderate |
| Neutral | Mixed tolerability; need for schedule adjustments | Common |
| Negative | Headache, dizziness, cost and access concerns | Frequent |
If side‑effects are troublesome, do not stop suddenly without advice.
Report severe effects such as fainting, chest pain that does not respond, or severe hypotension to your GP or pharmacist immediately.
Access & Purchase Options (Australia)
National Chains (Chemist Warehouse, Priceline, TerryWhite Chemmart)
Isosorbide mononitrate products are supplied through major chains and independent pharmacies in markets recorded in the raw data.
Products are prescription‑only as per the listed classification, and pricing varies by brand and retailer.
In our online pharmacy, monodur is available without a prescription, with discreet delivery to Australia in 9-21 days.
Online Pharmacies And Telehealth E‑Prescriptions
Telehealth e‑prescriptions are accepted by Australian pharmacies and many retailers offer click‑and‑collect or home delivery.
Rural patients may need to plan repeats or use postal delivery to ensure continuity.
- What To Bring To The Pharmacy:
- Current medication list.
- Recent blood pressure readings if available.
- Valid prescription or e‑prescription details.
- Concession or health care card for PBS claims.
| Access Mode | Notes |
|---|---|
| In‑store | Immediate pharmacist counselling and PBS claims where applicable. |
| Online | Click‑and‑collect or home delivery; check identity and prescription requirements. |
| Telehealth | E‑prescriptions accepted by most pharmacies; ensure full medication history is shared. |
Mechanism & Pharmacology
Simplified Explanation
Isosorbide mononitrate is an organic nitrate that donates nitric oxide‑like activity in vascular smooth muscle.
Vasodilation, especially venodilation, reduces cardiac preload and myocardial oxygen demand, which helps prevent angina.
The ATC code is C01DA14, placing it within cardiac therapy — nitrates.
Clinical Terms
- Immediate‑Release (IR)
- Faster onset of action with shorter duration and more frequent dosing.
- Extended‑Release (ER)
- Modified/retard formulations for once‑daily coverage (Monoket retard types are examples in the raw data).
- Nitrate‑Free Interval
- A daily period of at least 10–12 hours to reduce tolerance from continuous exposure.
- ATC Code
- C01DA14 — isosorbide mononitrate.
- Clinical pearl: ER forms improve adherence but still require a nitrate‑free period to limit tolerance.
- Onset and duration differ between IR and ER; counselling should reflect the chosen formulation.
Indications & Off‑Label Uses
Approved Indications By TGA
The principal approved use recorded in the raw data is prophylaxis of angina pectoris (stable angina).
Isosorbide mononitrate is for chronic prevention, not for acute relief of an angina attack.
Acute attacks require fast‑acting nitrates such as sublingual nitroglycerin.
Off‑Label Uses In Australian Clinical Practice
Some specialists may use low doses of isosorbide mononitrate as an adjunct in selected cases of heart failure or other ischaemic conditions.
The raw data notes off‑label adjunct dosing of around 10–20 mg twice daily in specialist settings.
| Indication | Evidence Level | Prescriber Considerations |
|---|---|---|
| Stable Angina | Established for symptom prophylaxis | Monitor BP; use nitrate‑free interval |
| Heart Failure (Adjunct) | Off‑label; specialist supervised | Start low; monitor for hypotension |
- Prescribers should weigh contraindications and drug interactions before using off‑label.
Key Clinical Findings
Clinical evidence and practice show isosorbide mononitrate reduces angina frequency when used correctly with nitrate‑free intervals.
Tolerance from continuous dosing is the main limitation to long‑term efficacy.
Adverse events are dominated by headache, dizziness and hypotension as per the raw data.
There is no clear mortality benefit; symptomatic relief is the principal goal.
- Ensure correct dosing schedule and educate patients about nitrate‑free periods.
- Monitor blood pressure and review concomitant therapies, especially PDE‑5 inhibitors.
- Use specialist guidance for off‑label or complex cases.
| Outcome | Typical Effect |
|---|---|
| Symptom Reduction | Moderate reduction in angina attacks when adhered to |
| Side‑Effect Incidence | High incidence of headache; dizziness common |
Alternatives Matrix
PBS‑Listed Alternatives Comparison Table
| Drug | Indication | Mode | Pros | Cons | PBS Status |
|---|---|---|---|---|---|
| Isosorbide Dinitrate | Angina prevention | Oral, spray, IV | Established alternative | Tolerance risk; more frequent dosing for IR forms | Check current PBS |
| Nitroglycerin (Sublingual) | Acute angina relief | Sublingual spray/tablet | Rapid onset for attacks | Short duration, not for prevention | Check current PBS |
| Nicorandil | Chronic angina | Oral tablet | Longer duration; different mechanism | Ulceration risk in some patients | Check current PBS |
| Ranolazine | Chronic angina | Oral tablet | Different mechanism, no nitrate tolerance | Cost and availability vary | Check current PBS |
| Beta‑Blockers / CCBs | Chronic angina | Oral tablets | Primary non‑nitrate options for prevention | Contraindications in certain comorbidities | Check current PBS |
- Pros/cons checklist for counselling: onset of action, tolerance risk, hypotension risk, comorbidity suitability, PBS subsidy status.
Common Questions (Pharmacy Consultations)
Pharmacists field the same core questions repeatedly about isosorbide mononitrate.
- Why Do I Get Headaches? — Headaches are caused by vasodilation and are often transient; analgesia or dose timing may help.
- Will I Become Tolerant? — Continuous exposure increases tolerance; a nitrate‑free interval reduces that risk.
- Can I Mix With My Other BP Meds? — Review is required; combined use increases hypotension risk and needs monitoring.
- Escalation Triggers:
- Syncope or loss of consciousness.
- Severe hypotension unresponsive to simple measures.
- Chest pain at rest that does not respond to prescribed therapy.
Provide a written action plan and ensure the patient carries an up‑to‑date medication list.
Price & Access Comparison Table
Prices vary by brand, pack size and retailer; PBS subsidy can significantly reduce cost when applicable.
| Source | Brand/Generic | Typical Retail Price Range (AUD) | PBS Status | Rx Required |
|---|---|---|---|---|
| Chemist Warehouse | Monoket / Generic | Varies by pack size | Check current PBS | Yes |
| Priceline | Generic / Brand | Varies by brand | Check current PBS | Yes |
| Local Pharmacy | Generic / Brand | Varies locally | Check current PBS | Yes |
| Online Pharmacy | Generic / Brand | Varies; delivery fees may apply | Check current PBS | Yes |
- Access checklist: concession card, repeats, telehealth scripts, postal delivery options for rural patients.
Registration & Regulation
TGA Approval
Confirm product registration on the TGA ARTG by searching the active substance or brand name.
Global suppliers listed in the raw data include Bayer, Atno, Krewel‑Meuselbach and Zentiva; Australian suppliers should be verified via ARTG entries.
PBS Subsidy Details
PBS listings and restrictions change; always verify the current PBS schedule before advising on subsidised cost or prescribing requirements.
- Steps to verify registration/PBS status:
- Search the TGA ARTG for the product and sponsor.
- Check the PBS schedule for listings and eligibility criteria.
- Confirm any prescribing restrictions for subsidy claims.
- Checklist for pharmacists handling subsidy claims: confirm patient concession status, ensure correct PBS authority codes, retain prescriptions as required.
Storage & Handling
Household Storage In Australian Climate (Heat/Humidity)
Store below 25°C and protect from moisture and direct sunlight as stated in the raw data.
In hot or humid Australian regions recommend a cool, dry place away from the bathroom or direct heat sources.
Cold‑Chain Handling For Pharmacies
Isosorbide mononitrate is not a cold‑chain medication, but avoid excessive heat during transport and storage.
Blister packs and bottles reduce moisture ingress; keep the medicine in original packaging until use.
- Patient storage checklist:
- Store below 25°C in a cool cupboard.
- Keep away from children and pets.
- Do not store in the bathroom or near the oven.
- Return expired medicines to a pharmacy for safe disposal.
- Ambient
- Typical room temperature below 25°C.
- Controlled Room Temperature
- Conditions maintained by the pharmacy to avoid extremes.
Guidelines For Proper Use (Pharmacist Counselling)
Australian Pharmacist Counselling Style
Counselling should confirm indication, review concurrent medicines and explain dosing clearly.
Emphasise the need for a nitrate‑free interval of 10–12 hours to reduce tolerance.
- Key counselling points:
- Confirm stable angina as the indication for use.
- Ask specifically about PDE‑5 inhibitor use and recent head trauma.
- Explain IR versus ER dosing and timing of nitrate‑free intervals.
- Warn about headaches and orthostatic hypotension, and advise on simple mitigations (sitting when dosing until effects known).
- Advise what to do for a missed dose and signs of overdose.
Patient Advice From PBS And National Health Authorities
Provide printed medicine information where available and a follow‑up plan for monitoring blood pressure and tolerability.
- Counselling checklist:
- Give a warning card about interactions (especially PDE‑5 inhibitors).
- Provide an action plan for adverse effects and emergency instructions.
- Arrange follow‑up review with the GP after initiation or dose changes.
Suggested patient handout should include dose timing, nitrate‑free interval guidance and emergency contact instructions.
Delivery Across Australia
| City | Region | Delivery time |
|---|---|---|
| Sydney | New South Wales | 9-14 days |
| Melbourne | Victoria | 9-14 days |
| Brisbane | Queensland | 9-14 days |
| Perth | Western Australia | 9-14 days |
| Adelaide | South Australia | 9-14 days |
| Canberra | Australian Capital Territory | 9-14 days |
| Hobart | Tasmania | 9-14 days |
| Darwin | Northern Territory | 9-14 days |
| Gold Coast | Queensland | 9-14 days |
| Newcastle | New South Wales | 9-14 days |
| Wollongong | New South Wales | 9-14 days |
| Geelong | Victoria | 9-14 days |
| Cairns | Queensland | 14-21 days |
| Townsville | Queensland | 14-21 days |
Purchase Context And Final Notes
Monodur is a trade or focus keyword commonly used for isosorbide mononitrate in pharmacy searches.
Products and brand availability vary by supplier and registration; confirm ARTG entries and PBS listings when advising on supply and cost.
For best practice, keep blood pressure monitoring records, maintain the nitrate‑free interval and seek medical review for severe side‑effects or new symptoms.
Pharmacists should flag any prescription requests that conflict with absolute contraindications, particularly concurrent PDE‑5 inhibitor use.
When in doubt consult Therapeutic Guidelines (Cardiology) or the TGA/PBS resources for the most current Australian guidance.